Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HILL HEALTH REFORM DEBATE WILL START IN LATE JANUARY WITH STARK HEARING

Executive Summary

The House Ways & Means/Health Subcommittee will kick off this year's debate on health care reform legislation with hearings planned for late January. The hearings will focus on legislation introduced Jan. 5 by Subcommittee Chairman Stark (D-Calif.). The bill, HR 200, is "90%" the same as last session's HR 5502, introduced in June by Stark and House Majority Leader Gephardt (D-Mo.), with provisions added to build a framework for "managed competition" in the health care system, Stark staffers explained. The bill's Medicare provisions include coverage of outpatient prescription drugs, starting with a $500 deductible in the first year. Notwithstanding HR 200's introduction, Stark has not altered his stated intention to support President-elect Clinton's upcoming health care reform plan. Rather, Stark's intention is to build consensus in areas such as administrative simplification, fraud and abuse enforcement, insurance reforms and establishment of a standard benefit package. Those provisions are included in many health care reform plans and also are likely to be a part of the Clinton package. Like last year's Stark/Gephardt bill, HR 200 would phase in a national health budget that would eventually hold growth in health spending to that of the nominal gross domestic product. The bill would provide grants to states totaling $150 mil. to establish health plan purchasing cooperatives, one of the cornerstones of the managed competition approach. HR 200's managed competition provisions would be less regulatory than those in many other bills. Enrollment in HPPCs would be voluntary tax deductibility of health insurance premiums would not be limited to programs handled by the HPPCs. The bill also contains a number of insurance reforms, such as restrictions on excluding pre-existing conditions from coverage.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel